KMT2A: Umbrella Gene for Multiple Diseases

Area of Science:

• Epigenetics
• Molecular Biology
• Genetics

Background:

• KMT2A (Lysine methyltransferase 2A) is a key epigenetic regulator involved in histone methylation (H3K4).
• Dysfunctional KMT2A is implicated in developmental disorders like Wiedemann-Steiner syndrome and various chromatinopathies.
• Somatic KMT2A mutations are frequently observed in hematological malignancies.

Purpose of the Study:

• To review the multifaceted roles of KMT2A in health and disease.
• To highlight the investigation of epigenetic therapies for KMT2A-associated disorders.
• To discuss potential therapeutic strategies including pharmaceuticals and nutritional interventions.

Main Methods:

• Literature review of KMT2A function, mutations, and therapeutic interventions.
• Analysis of animal models to understand KMT2A's role in development and hematopoiesis.
• Examination of current research on epigenetic treatments and microbiota-based interventions.

Main Results:

• KMT2A mutations lead to a spectrum of overlapping developmental syndromes and are drivers in certain cancers.
• Animal models elucidate KMT2A's critical functions in embryonic development, hematopoiesis, and neurodevelopment.
• Epigenetic therapies and nutritional interventions targeting KMT2A dysfunction are under active investigation.

Conclusions:

• KMT2A is a critical gene with significant implications in both developmental disorders and cancer.
• Targeting KMT2A through epigenetic modifications offers promising therapeutic avenues.
• Further research into microbiota's role in epigenetic regulation may yield novel treatment strategies for KMT2A-related conditions.